Analysts Set Teladoc Health, Inc. (NYSE:TDOC) Price Target at $9.65

Shares of Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) have been given a consensus recommendation of "Hold" by the nineteen analysts that are covering the firm, Marketbeat Ratings reports. Twelve research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is $9.65.

A number of research firms have issued reports on TDOC. Canaccord Genuity Group decreased their price target on shares of Teladoc Health from $14.00 to $12.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Truist Financial decreased their price target on shares of Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a report on Tuesday, May 27th. The Goldman Sachs Group decreased their price target on shares of Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Stifel Nicolaus decreased their price target on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a report on Thursday, May 1st. Finally, Bank of America cut their price objective on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research report on Wednesday, May 28th.

Teladoc Health Stock Performance

TDOC stock traded down $0.39 during mid-day trading on Monday, reaching $8.20. 5,553,845 shares of the stock traded hands, compared to its average volume of 7,338,551. The company has a quick ratio of 1.64, a current ratio of 1.68 and a debt-to-equity ratio of 0.70. Teladoc Health has a 52 week low of $6.35 and a 52 week high of $15.21. The business has a 50-day moving average of $7.63 and a two-hundred day moving average of $8.61. The firm has a market capitalization of $1.44 billion, a PE ratio of -1.38 and a beta of 1.84.

Insider Buying and Selling

In other Teladoc Health news, insider Fernando M. Rodrigues sold 4,174 shares of the company's stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $6.91, for a total transaction of $28,842.34. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Adam C. Vandervoort sold 5,808 shares of the company's stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total transaction of $39,842.88. Following the sale, the insider directly owned 69,773 shares in the company, valued at $478,642.78. This represents a 7.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 18,656 shares of company stock valued at $128,189 over the last quarter. Corporate insiders own 0.58% of the company's stock.

Institutional Trading of Teladoc Health

Several large investors have recently added to or reduced their stakes in TDOC. Golden State Wealth Management LLC grew its stake in Teladoc Health by 102.6% during the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock worth $27,000 after buying an additional 1,690 shares during the last quarter. National Bank of Canada FI grew its stake in Teladoc Health by 79.4% during the first quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock worth $28,000 after buying an additional 1,581 shares during the last quarter. SVB Wealth LLC bought a new stake in Teladoc Health during the first quarter worth about $37,000. Sterling Capital Management LLC grew its stake in Teladoc Health by 776.7% during the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock worth $42,000 after buying an additional 4,101 shares during the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S bought a new stake in Teladoc Health during the first quarter worth about $50,000. 76.82% of the stock is owned by institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.